SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 4 CALLS ON FILE

VVOS — Vivos Therapeutics, Inc.

NASDAQ

FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 14, 2026

REVENUE

$5.2M +0.2%

NET MARGIN

-106.4% +44.4 PTS

EPS

-$0.31 +40.4%

FREE CASH FLOW

-$3.1M +47.9%

No summary has been written for this call yet.